Recent Security Class Actions

Mallinckrodt plc (NYSE: MNK)

Company Name:Mallinckrodt plc
Stock Symbol:NYSE: MNK
Class Period Start:05/03/2016
Class Period End (inclusive):03/13/2020
Filing Deadline:09/24/2019

According to the Plaintiff’s law firm press release, Mallinckrodt, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza. The Company markets its branded products to physicians, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies.